BNP Paribas Financial Markets’s AYTU BioPharma AYTU Stock Holding History

BNP Paribas Financial Markets’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49	Hold	23	–	–	﹤0.01%	5829
2026 Q1	$63	Hold	23	–	–	﹤0.01%	5710
2025 Q4	$60	Hold	23	–	–	﹤0.01%	5636
2025 Q3	$43	Hold	23	–	–	﹤0.01%	5477
2025 Q2	$50	Hold	23	–	–	﹤0.01%	5356
2025 Q1	$28	Hold	23	–	–	﹤0.01%	5310
2024 Q4	$39	Buy	+23	New	+$42	﹤0.01%	5326
2022 Q4	–	Sell	-26	Closed	-$97	–	4097
2022 Q3	$97	Buy	+26	New	+$197	﹤0.01%	4650
2020 Q4	–	Sell	-35	Closed	-$8.34K	–	4145
2020 Q3	$8.34K	Buy	35 +31	+775%	+$7.97K	﹤0.01%	3976
2020 Q2	$1.22K	Buy	+4	New	+$1.21K	﹤0.01%	4191

Other funds holding AYTU

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return

Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BNP Paribas Financial Markets's AYTU Position: Q2 2026 in Review

BNP Paribas Financial Markets held its AYTU BioPharma (AYTU) position steady in Q2 2026 at 23 shares worth $49. The position accounts for ﹤0.01% of the portfolio, ranked #5829.

BNP Paribas Financial Markets first reported a position in AYTU in Q2 2020 and has held it in 10 quarters since. The position peaked at $8.34K in Q3 2020. 38 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

BNP Paribas Financial Markets held 23 shares of AYTU BioPharma worth $49 as of Q2 2026.
BNP Paribas Financial Markets left its AYTU BioPharma share count unchanged in Q2 2026.
AYTU BioPharma made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5829 holding.
BNP Paribas Financial Markets first reported a position in AYTU BioPharma in Q2 2020 and has held it in 10 quarters since.
BNP Paribas Financial Markets's AYTU BioPharma position peaked at $8.34K in Q3 2020.
38 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.